Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States

Cancer - Tập 119 Số 5 - Trang 1089-1097 - 2013
B. Ashleigh Guadagnolo1, Jinhai Huo1, Kaiping Liao2, Thomas A. Buchholz1, Prajnan Das1
1Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas
2Section of Health Services Research, Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas

Tóm tắt

AbstractBACKGROUND:Our goal was to investigate utilization trends for advanced radiation therapy (RT) technologies, such as intensity‐modulated radiation therapy (IMRT) and stereotactic radiosurgery (SRS), in the last year of life among patients diagnosed with metastatic cancer.METHODS:We used the Surveillance, Epidemiology and End Results (SEER)‐Medicare linked databases to analyze claims data in the last 12 months of life for 64,525 patients diagnosed with metastatic breast, colorectal, lung, pancreas, and prostate cancers from 2000 to 2007. Logistic regression modeling was conducted to analyze potential demographic, health services, and treatment‐related variables' influences on receipt of advanced RT.RESULTS:Among the 19,161 (29.7%) patients who received radiation therapy, there was a significant decrease in the proportion of patients who received the simplest radiation technique (ie, 2D‐radiation therapy) (P < .0001), and significant increases in the proportions of patients receiving more advanced radiation techniques (ie, IMRT, and SRS; P < .0001 for all curves); although the rates for use of IMRT and SRS in 2007 remained under 5%. On multivariate analyses, receipt of RT varied significantly by non‐clinical characteristics such as race, marital status, neighborhood income, and SEER region. Patients who received hospice care in the last year of life were more likely to receive radiation therapy (OR = 1.35, 95% CI = 1.30‐1.40) but less likely to be treated with IMRT (OR = 0.76, 95% CI = 0.62‐0.92).CONCLUSIONS:Although the proportion of patients receiving RT in the last year of life for metastatic cancer did not change for most of the past decade, we observed significant trends toward more advanced radiation techniques. Cancer 2013. © 2012 American Cancer Society.

Từ khóa


Tài liệu tham khảo

Carreyrou J, 2010, A device to kill cancer, lift revenue, Wall Street Journal., A1

10.1002/cncr.21284

10.1016/S1470-2045(08)70098-6

10.1586/erp.10.51

10.1111/j.1475-6773.2010.01082.x

National Cancer Institute. Surveillance Epidemiology and End Results program.http://seer.cancer.gov/index.html. Accessed August 7 2012.

10.1097/00005650-199308000-00006

10.1097/00005650-200208001-00002

10.3322/caac.20073

US Department of Health and Human Services Health Resources and Services Administration. Area Resource File (ARF): 2009–2010. Rockville MD: Health Resources and Services Administration Bureau of Health Professions.www.arf.hrsa.gov. Accessed August 6 2012.

10.1016/0021-9681(87)90171-8

10.1016/S0895-4356(00)00256-0

10.1097/01.mlr.0000223480.52713.b9

10.1016/j.annepidem.2007.03.011

10.1093/jnci/djr100

10.1056/NEJMp1113059

10.1089/jpm.2009.9633

10.1586/era.11.165

10.1097/COC.0b013e31822dfd71

10.1016/j.ijrobp.2011.07.020

10.4143/crt.2011.43.2.75

10.1200/JCO.2010.30.1655

10.1001/jama.295.21.2483

10.1016/S1470-2045(09)70263-3

10.1002/cncr.26505

10.1016/S0027-9684(15)30410-7

10.1056/NEJMp1110117